Parveen, Saaima
Zareini, Bochra
Arulmurugananthavadivel, Anojhaan
Kistorp, Caroline
Faber, Jens
Køber, Lars
Hassager, Christian
Sørensen, Tor Biering
Andersson, Charlotte
Zahir, Deewa
Iversen, Kasper
Wolsk, Emil
Gislason, Gunnar
Gaborit, Freja
Schou, Morten
Article History
Received: 19 October 2021
Accepted: 24 February 2022
First Online: 21 March 2022
Declarations
:
: The Copenhagen Heart Failure Risk Study was approved by the Ethical Region of The Capital Region (H-3–2014-016) and conducted according to the Declaration of Helsinki. All patients provided written informed consent for their participation in the study<i>.</i>
: Not applicable
: Dr. Kober reports personal fees from Speaers honorarium from Novartis, AstraZeneca, Boehringer and Novo, outside the submitted work. None declared from the other co-authors.